Literature DB >> 11441011

Physical mapping of HIV reverse transcriptase to the 5' end of RNA primers.

J J DeStefano1, J V Cristofaro, S Derebail, W P Bohlayer, M J Fitzgerald-Heath.   

Abstract

Enzymatic analysis of RNA cleavage products has suggested that human immunodeficiency virus (HIV) reverse transcriptase (RT) binds to the 5' end of RNAs that are recessed on a longer DNA template (RNA primers) yet binds to the 3' end of DNA primers. One concern is that RT molecules bound at the 3' end of RNA would not be easily detected because RT may not catalyze substantial RNA extension or cleavage when bound to the 3' end. We used physical mapping to show that RT binds preferentially to the 5' end of RNA primers. An HIV-RT that lacked RNase H activity (HIV-RT(E478Q)) was incubated with the RNA-DNA hybrid followed by the addition of Escherichia coli RNase H. RT protected a approximately 23-base region at the 5' end of the RNA and 4 additional bases on the DNA strand. This footprint correlated well with the crystal structure of HIV-RT. No protection of the RNA 3' end was observed, although when dNTPs were included, low levels of extension occurred, indicating that RT can bind this end. Wild-type HIV-RT cleaved the RNA and then extended a small portion of the cleaved fragments, suggesting that very small RNAs may be bound similar to DNA primers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11441011     DOI: 10.1074/jbc.M103958200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Specific cleavages by RNase H facilitate initiation of plus-strand RNA synthesis by Moloney murine leukemia virus.

Authors:  Sharon J Schultz; Miaohua Zhang; James J Champoux
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 2.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

3.  Tighter binding of HIV reverse transcriptase to RNA-DNA versus DNA-DNA results mostly from interactions in the polymerase domain and requires just a small stretch of RNA-DNA.

Authors:  William P Bohlayer; Jeffrey J DeStefano
Journal:  Biochemistry       Date:  2006-06-20       Impact factor: 3.162

4.  Preferred sequences within a defined cleavage window specify DNA 3' end-directed cleavages by retroviral RNases H.

Authors:  Sharon J Schultz; Miaohua Zhang; James J Champoux
Journal:  J Biol Chem       Date:  2009-09-24       Impact factor: 5.157

5.  Duplex structural differences and not 2'-hydroxyls explain the more stable binding of HIV-reverse transcriptase to RNA-DNA versus DNA-DNA.

Authors:  Jeffrey T Olimpo; Jeffrey J DeStefano
Journal:  Nucleic Acids Res       Date:  2010-03-24       Impact factor: 16.971

6.  The role of template-primer in protection of reverse transcriptase from thermal inactivation.

Authors:  Gary F Gerard; R Jason Potter; Michael D Smith; Kim Rosenthal; Gulshan Dhariwal; Jun Lee; Deb K Chatterjee
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

7.  A new role for HIV nucleocapsid protein in modulating the specificity of plus strand priming.

Authors:  Deena T Jacob; Jeffrey J DeStefano
Journal:  Virology       Date:  2008-07-15       Impact factor: 3.616

Review 8.  RNase H activity: structure, specificity, and function in reverse transcription.

Authors:  Sharon J Schultz; James J Champoux
Journal:  Virus Res       Date:  2008-02-07       Impact factor: 3.303

9.  Human immunodeficiency virus type 2 reverse transcriptase activity in model systems that mimic steps in reverse transcription.

Authors:  Klara Post; Jianhui Guo; Kathryn J Howard; Michael D Powell; Jennifer T Miller; Amnon Hizi; Stuart F J Le Grice; Judith G Levin
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Fidelity of plus-strand priming requires the nucleic acid chaperone activity of HIV-1 nucleocapsid protein.

Authors:  Klara Post; Besik Kankia; Swathi Gopalakrishnan; Victoria Yang; Elizabeth Cramer; Pilar Saladores; Robert J Gorelick; Jianhui Guo; Karin Musier-Forsyth; Judith G Levin
Journal:  Nucleic Acids Res       Date:  2009-01-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.